This website is part of the ECDC (European Centre for Disease Prevention and Control) network
ECDC logo
Contact Sitemap Links RSS feeds
Font:
Accessibility
 
European Center for Disease Prevention and Control






Go to extranet
   
Skip Navigation Links
Home
About Us
Activities
Health Topics
Publications
Media Centre
You are here: Skip Navigation LinksECDC Portal > English > Health Topics > Seasonal influenza > Antivirals

 READ MORE ON ECDC SITE

 EXTERNAL LINKS
 
Skip navigation links
What’s new
Key messages
Basic facts
Epidemiological data
Risk assessments
Personal protective measures
Seasonal influenza vaccines
Antivirals
Q&A on antivirals
Antiviral resistance - Oseltamivir resistance
Communication toolkit
Multimedia and tools
External sites
Antivirals 

Monitoring of antiviral resistance in EU for the season 2008-09 is currently ongoing. The coordinators of The Community Network of Reference Laboratories for Human Influenza in Europe (CNRL), routinely collect, analyze and disseminate information on antiviral resistance from Influenza viruses isolated from 25 European (European Union, EEA/EFTA) countries.

The analysis of resistance against Neuraminidase Inhibitors and Adamantanes is done by measuring IC50 values and/or by genotyping of viruses for detection of known drug resistance mutations.

Summary information on antiviral resistance in EU is published in the Weekly Influenza Surveillance Overview (WISO).

 SECTIONS

Q&A on antivirals
What are the uses of antivirals against seasonal influenza?” When are antivirals effective? If I need them how quickly should I take them? Which are the antivirals we use in Europe against seasonal influenza and who should get them?...

Antiviral resistance - Oseltamivir resistance
How did WHO, the European Commission, the ECDC (European Centre for Disease Prevention and Control) and the European Medicines Agency learn about oseltamivir resistance in influenza viruses? Q2. Has oseltamivir resistance been found in other countries this influenza season?...

 
   Share